Hospitals in Oxfordshire have introduced a genetic test which helps doctors predict the dangerous side effects of chemotherapy.
In total, 600 cancer patients at the Cancer and Haematology Centre at the Churchill Hospital in Oxford and the Horton General Hospital in Banbury will undergo a blood test prior to treatment to predict potential side effects of two commonly used cancer drugs - capecitabine and fluorouracil (5FU).